Founded in 2012, mySugr is a digital health company that aims to simplify life with diabetes. We give people with diabetes the tools, know-how, and confidence to ease the complexity of their daily diabetes routine. mySugr is a top companion to monitor and manage your diabetes with all relevant information stored on your smartphone and ready to use. Stay in charge of your health, manage your insulin intake, and take control of your diabetes every day. In short, we aim to make diabetes suck less.
A part of the Roche family since 2017, mySugr is based in Vienna, Austria. The company has over 4 million registered users in more than 80 countries worldwide and continues to keep on growing.
The mySugr Quality Management System is certified under EN ISO 13485:2016. Under EU regulations, the mySugr Logbook is a Class IIa medical device and the mySugr Bolus Calculator is a Class IIb medical device. The mySugr Logbook is available as an exempt device under FDA regulation in the United States.
We envision a world where people with diabetes can live full and healthy lives, free from worrying about the daily grinds of their therapy.
mySugr aims to be the most reliable, supportive, and empathetic brand on the planet for people living with diabetes. Through innovative products and human-centric experiences, mySugr helps customers tackle the challenges that accompany daily diabetes therapy.
Since 2017, mySugr has been a proud part of Roche Diabetes Care to help create an open digital diabetes ecosystem that revolves entirely around people with diabetes.
Want to learn more about mySugr & RocheDiabetes?
Managing Director (Trade Law) and Head of Regulatory Affairs
Head of Finance
Global Head of Digital Quality and Regulatory
Global Head of Digital Engineering
● Diabetes sucks
● Emergence of smart phone App Stores (2009)
● Prevalence of intimidating & distant communication for people living with diabetes
Living well with diabetes is possible, and the foundation of living well with diabetes is data – with data, therapy can be optimized. Diabetes data, however, can be inconvenient to collect, hard to analyze, and often downright overwhelming. People with diabetes can end up relying on doctors and diabetes educators for help, but can’t see them often enough, or for long enough, to get the help they need.